Samy A.F. Morad

1.9k total citations · 1 hit paper
33 papers, 1.2k citations indexed

About

Samy A.F. Morad is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Samy A.F. Morad has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Samy A.F. Morad's work include Sphingolipid Metabolism and Signaling (18 papers), Drug Transport and Resistance Mechanisms (10 papers) and Lipid Membrane Structure and Behavior (8 papers). Samy A.F. Morad is often cited by papers focused on Sphingolipid Metabolism and Signaling (18 papers), Drug Transport and Resistance Mechanisms (10 papers) and Lipid Membrane Structure and Behavior (8 papers). Samy A.F. Morad collaborates with scholars based in Egypt, United States and Germany. Samy A.F. Morad's co-authors include Myles C. Cabot, Mark Kester, Jonathan C. Levin, David J. Feith, Su‐Fern Tan, Tatiana Syrovets, Todd E. Fox, Thomas P. Loughran, Sriram S. Shanmugavelandy and Berthold Büchele and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature reviews. Cancer and Clinical Cancer Research.

In The Last Decade

Samy A.F. Morad

32 papers receiving 1.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ceramide-orchestrated signalling in cancer cells

2012 620 citations Samy A.F. Morad, Myles C. Cabot Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samy A.F. Morad Egypt	18	904	176	145	144	122	33	1.2k
Xuan Zhao China	13	1.1k 1.2×	91 0.5×	302 2.1×	90 0.6×	61 0.5×	40	1.4k
Daniel A. Bochar United States	19	1.9k 2.1×	101 0.6×	188 1.3×	138 1.0×	89 0.7×	28	2.1k
Renee Emkey United States	20	994 1.1×	182 1.0×	194 1.3×	50 0.3×	120 1.0×	37	1.3k
Jinu Lee South Korea	19	1.1k 1.3×	103 0.6×	171 1.2×	330 2.3×	138 1.1×	64	1.8k
Zhiping Wu United States	24	1.0k 1.1×	186 1.1×	180 1.2×	103 0.7×	198 1.6×	60	1.6k
Kristie L. Rose United States	23	1.3k 1.4×	124 0.7×	205 1.4×	198 1.4×	89 0.7×	47	1.7k
Astrid Slany Austria	24	686 0.8×	75 0.4×	188 1.3×	164 1.1×	80 0.7×	40	1.3k
Kazushi Sugihara Japan	17	719 0.8×	342 1.9×	138 1.0×	135 0.9×	82 0.7×	24	1.1k
Xusheng Wang United States	24	1.3k 1.4×	140 0.8×	147 1.0×	112 0.8×	288 2.4×	68	1.9k
Rosalba D’Alessandro Italy	22	841 0.9×	134 0.8×	265 1.8×	272 1.9×	82 0.7×	55	1.6k

Countries citing papers authored by Samy A.F. Morad

Since Specialization

Citations

This map shows the geographic impact of Samy A.F. Morad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samy A.F. Morad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samy A.F. Morad more than expected).

Fields of papers citing papers by Samy A.F. Morad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samy A.F. Morad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samy A.F. Morad. The network helps show where Samy A.F. Morad may publish in the future.

Co-authorship network of co-authors of Samy A.F. Morad

This figure shows the co-authorship network connecting the top 25 collaborators of Samy A.F. Morad. A scholar is included among the top collaborators of Samy A.F. Morad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samy A.F. Morad. Samy A.F. Morad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brito‐Casillas, Yeray, et al.. (2024). The Acacia (Vachellia nilotica (L.) P.J.H. Hurter & Mabb.): Traditional Uses and Recent Advances on Its Pharmacological Attributes and Potential Activities. Nutrients. 16(24). 4278–4278. 3 indexed citations

Hassan, Reham, Maiju Myllys, Daniela González, et al.. (2024). Acetaminophen overdose causes a breach of the blood–bile barrier in mice but not in rats. Archives of Toxicology. 98(5). 1533–1542. 2 indexed citations

Morad, Samy A.F., et al.. (2023). The evaluation of the safety and toxicological characteristics of Acacia nilotica in broiler. SHILAP Revista de lepidopterología. 6(2). 124–135. 2 indexed citations

Haridy, Mohie, Reham Hassan, Madeha Ahmed Hashim, et al.. (2023). Vinpocetine protects against chloroquine-induced cardiotoxicity by mitigating oxidative stress. Archives of Toxicology. 97(10). 2763–2770. 2 indexed citations

Omar, Mosaab A., et al.. (2022). An in vitro evaluation of the inhibitory effects of an aqueous extract of Acacia nilotica on Eimeria tenella.. SHILAP Revista de lepidopterología. 5(4). 33–40. 4 indexed citations

Gaafary, Menna El, Samy A.F. Morad, Michael Schmiech, Tatiana Syrovets, & Thomas Simmet. (2022). Arglabin, an EGFR receptor tyrosine kinase inhibitor, suppresses proliferation and induces apoptosis in prostate cancer cells. Biomedicine & Pharmacotherapy. 156. 113873–113873. 10 indexed citations

Metwally, Asmaa A., et al.. (2020). Wound-Healing Activity of Green and Chemical Zinc Oxide Nanoparticles (ZnO-NPs) Gels in Equine Wounds: A clinical Study. SHILAP Revista de lepidopterología. 3(1). 66–79. 11 indexed citations

Morad, Samy A.F., Miki Kassai, Todd E. Fox, et al.. (2019). Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells. Journal of Lipid Research. 60(9). 1590–1602. 25 indexed citations

Morad, Samy A.F., et al.. (2017). Oleanolic acid methyl ester, a novel cytotoxic mitocan, induces cell cycle arrest and ROS-Mediated cell death in castration-resistant prostate cancer PC-3 cells. Biomedicine & Pharmacotherapy. 96. 417–425. 21 indexed citations

10.

Morad, Samy A.F., et al.. (2016). Short-chain ceramides depress integrin cell surface expression and function in colorectal cancer cells. Cancer Letters. 376(2). 199–204. 13 indexed citations

11.

Morad, Samy A.F., P. Darrell Neufer, Tonya N. Zeczycki, et al.. (2016). Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia. Journal of Lipid Research. 57(7). 1231–1242. 23 indexed citations

12.

Morad, Samy A.F., Lance C. Bridges, & Myles C. Cabot. (2015). Abstract A31: Revisited use of tamoxifen for improving melanoma therapy. Clinical Cancer Research. 21(4_Supplement). A31–A31. 1 indexed citations

13.

Morad, Samy A.F., et al.. (2015). Dynamics of ceramide generation and metabolism in response to fenretinide – Diversity within and among leukemia. Leukemia Research. 39(10). 1071–1078. 14 indexed citations

14.

Barth, Brian M., et al.. (2013). Gaucher's Disease and Cancer: A Sphingolipid Perspective. Critical Reviews™ in Oncogenesis. 18(3). 221–234. 26 indexed citations

15.

Morad, Samy A.F., James P. Madigan, Jonathan C. Levin, et al.. (2013). Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53. Biochemical Pharmacology. 85(8). 1057–1065. 34 indexed citations

16.

Morad, Samy A.F., Jonathan C. Levin, Su‐Fern Tan, et al.. (2013). Novel off-target effect of tamoxifen — Inhibition of acid ceramidase activity in cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(12). 1657–1664. 47 indexed citations

17.

Morad, Samy A.F., Berthold Büchele, Hans‐Ullrich Siehl, et al.. (2012). A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells. Molecular Pharmacology. 83(2). 531–541. 34 indexed citations

18.

Morad, Samy A.F., Jonathan C. Levin, Sriram S. Shanmugavelandy, et al.. (2012). Ceramide–Antiestrogen Nanoliposomal Combinations—Novel Impact of Hormonal Therapy in Hormone-Insensitive Breast Cancer. Molecular Cancer Therapeutics. 11(11). 2352–2361. 43 indexed citations

19.

Morad, Samy A.F. & Myles C. Cabot. (2012). Ceramide-orchestrated signalling in cancer cells. Nature reviews. Cancer. 13(1). 51–65. 620 indexed citations breakdown →

20.

Syrovets, Tatiana, Oleg Lunov, Berthold Büchele, et al.. (2009). Tirucallic Acids Are Novel Pleckstrin Homology Domain-Dependent Akt Inhibitors Inducing Apoptosis in Prostate Cancer Cells. Molecular Pharmacology. 77(3). 378–387. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact